UNDBIO, Inc

UNDBIO is a Biotechnology, Pharmaceuticals, Marketing and Distribution company with a mission to Inspire a healthier world and use a platform technology skillset to help humanity for a healthy, disease-free world. And to be a company that can provide opportunities to achieve and improve the quality of human life. UNDBIO is adopting lean models of Insulin, Insulin Analogs and other biosimilars development and rapidly evolving technologies such as data platforms and data analytics to help reduce the residual uncertainties that require new biosimilars to be subjected to human trials. This will accelerate development and reduce costs. UNBIO follows a logical step wise progression to ensure that a global development plan can be leveraged to satisfy regulators in each potential market. This creates a clear Regulatory Strategic Road Map, appropriate Clinical strategy and trial design, and commercial, market access considerations. UNDBIO believes that effective commercial approaches strike a balance between different imperatives: making the product more affordable for patients and building tender capabilities to secure volume gains; generating further savings for payers and providers through incentives; and tailoring pricing and channel strategies to individual products and countries to achieve traction at physician level.